Beam Therapeutics, Inc. (BEAM)
24.50
+0.11
(+0.45%)
USD |
NASDAQ |
Oct 02, 16:00
24.50
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics EPS Diluted (Quarterly) : -1.176 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.176 |
| March 31, 2026 | -0.9134 |
| December 31, 2025 | 2.328 |
| September 30, 2025 | -1.099 |
| June 30, 2025 | -1.001 |
| March 31, 2025 | -1.231 |
| December 31, 2024 | -1.091 |
| September 30, 2024 | -1.173 |
| June 30, 2024 | -1.106 |
| March 31, 2024 | -1.208 |
| December 31, 2023 | 1.727 |
| September 30, 2023 | -1.216 |
| June 30, 2023 | -1.084 |
| March 31, 2023 | -1.335 |
| December 31, 2022 | -0.5418 |
| September 30, 2022 | -1.558 |
| Date | Value |
|---|---|
| June 30, 2022 | -1.025 |
| March 31, 2022 | -1.007 |
| December 31, 2021 | -0.9517 |
| September 30, 2021 | -0.4236 |
| June 30, 2021 | -1.226 |
| March 31, 2021 | -3.348 |
| December 31, 2020 | -1.688 |
| September 30, 2020 | -0.6878 |
| June 30, 2020 | -0.6922 |
| March 31, 2020 | -1.033 |
| December 31, 2019 | -0.606 |
| September 30, 2019 | -0.4345 |
| June 30, 2019 | -0.4107 |
| March 31, 2019 | -0.3228 |
| December 31, 2018 | -0.5132 |
| September 30, 2018 | -1.374 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.7989 |
| Twist Bioscience Corp. | -0.5617 |
| Prime Medicine, Inc. | -0.2376 |
| Q32 Bio, Inc. | -0.4398 |
| Sarepta Therapeutics, Inc. | -0.0464 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -122.68M |
| Revenue (Quarterly) | 0.49M |
| Total Expenses (Quarterly) | 123.17M |
| Enterprise Value | 1.624B |
| Gross Profit Margin (Quarterly) | -1.00K% |
| Profit Margin (Quarterly) | -25.04K% |
| Earnings Yield | -3.51% |
| Normalized Earnings Yield | -3.461 |